Incannex Healthcare Management
Management criteria checks 3/4
Incannex Healthcare's CEO is Joel Latham, appointed in Jun 2018, has a tenure of 5.92 years. total yearly compensation is $2.02M, comprised of 27% salary and 73% bonuses, including company stock and options. directly owns 9.94% of the company’s shares, worth $3.64M. The average tenure of the management team and the board of directors is 3.2 years and 4.7 years respectively.
Key information
Joel Latham
Chief executive officer
US$2.0m
Total compensation
| CEO salary percentage | 27.0% |
| CEO tenure | 5.9yrs |
| CEO ownership | 9.9% |
| Management average tenure | 3.2yrs |
| Board average tenure | 4.7yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$21m |
| Sep 30 2023 | n/a | n/a | US$5m |
| Jun 30 2023 | US$2m | US$546k | -US$13m |
| Mar 31 2023 | n/a | n/a | -US$13m |
| Dec 31 2022 | n/a | n/a | -US$48m |
| Sep 30 2022 | n/a | n/a | -US$28m |
| Jun 30 2022 | US$1m | US$368k | -US$10m |
| Mar 31 2022 | n/a | n/a | -US$10m |
| Dec 31 2021 | n/a | n/a | -US$9m |
| Sep 30 2021 | n/a | n/a | -US$9m |
| Jun 30 2021 | US$477k | US$209k | -US$9m |
| Dec 31 2020 | n/a | n/a | -US$4m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | US$269k | US$157k | -US$3m |
| Dec 31 2019 | n/a | n/a | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$1m |
| Jun 30 2019 | US$144k | US$119k | -US$1m |
| Mar 31 2019 | n/a | n/a | -US$2m |
| Dec 31 2018 | n/a | n/a | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$2m |
| Jun 30 2018 | US$120k | US$90k | -US$2m |
Compensation vs Market: Joel's total compensation ($USD2.02M) is above average for companies of similar size in the US market ($USD667.96K).
Compensation vs Earnings: Joel's compensation has been consistent with company performance over the past year.
CEO
Joel Latham (33 yo)
5.9yrs
Tenure
US$2,020,758
Compensation
Mr. Joel Bradley Latham has been Chief Executive Officer at Incannex Healthcare Limited (also known as Impression Healthcare Ltd.) since June 29, 2018, Managing Director and Executive Director since July 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 5.9yrs | US$2.02m | 9.94% $ 3.6m | |
| Chief Technical Officer | 1.9yrs | US$104.90k | no data | |
| CFO, Treasurer & Secretary | less than a year | no data | 0.0016% $ 575.7 | |
| Chief Scientific Officer | no data | no data | no data | |
| Chief Executive Officer of IncannexTM | 4.5yrs | no data | no data | |
| VP of Clinical Operations & Member of the Advisory Board | no data | no data | no data |
3.2yrs
Average Tenure
33yo
Average Age
Experienced Management: IXHL's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 4.8yrs | US$2.02m | 9.94% $ 3.6m | |
| Chief Scientific Officer | no data | no data | no data | |
| VP of Clinical Operations & Member of the Advisory Board | no data | no data | no data | |
| Member of the Advisory Board | no data | no data | no data | |
| Non-Executive Director | 1.9yrs | US$117.13k | 4.85% $ 1.8m | |
| Independent Non-Executive Chairman | 6.4yrs | US$916.98k | 1.18% $ 432.7k | |
| Independent Non-Executive Director | 6.2yrs | US$210.62k | 1.71% $ 625.7k | |
| Member of Medical Advisory Board | 4.7yrs | no data | no data | |
| Member of Medical Advisory Board | 3.7yrs | no data | no data | |
| Member of the Advisory Board | no data | no data | no data | |
| Non-Executive Director | 1.8yrs | US$117.28k | 0.63% $ 231.0k |
4.7yrs
Average Tenure
52.5yo
Average Age
Experienced Board: IXHL's board of directors are considered experienced (4.7 years average tenure).